Chongkundang (001630) - Total Liabilities
Based on the latest financial reports, Chongkundang (001630) has total liabilities worth ₩713.67 Billion KRW (≈ $483.64 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 001630 operating cash flow to assess how effectively this company generates cash.
Chongkundang - Total Liabilities Trend (2000–2024)
This chart illustrates how Chongkundang's total liabilities have evolved over time, based on quarterly financial data. Check 001630 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Chongkundang Competitors by Total Liabilities
The table below lists competitors of Chongkundang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Acme United Corporation
NYSE MKT:ACU
|
USA | $56.99 Million |
|
Piedmont Lithium Ltd ADR
NASDAQ:PLL
|
USA | $40.90 Million |
|
Kindly MD, Inc.
NASDAQ:NAKA
|
USA | $214.86 Million |
|
Orient Green Power Company Limited
NSE:GREENPOWER
|
India | Rs5.33 Billion |
|
Thryv Holdings Inc
NASDAQ:THRY
|
USA | $480.72 Million |
|
Enad Global 7 AB
ST:EG7
|
Sweden | Skr1.09 Billion |
|
EGH Acquisition Corp. Class A Ordinary Shares
NASDAQ:EGHA
|
USA | $6.10 Million |
|
Sula Vineyards Limited
NSE:SULA
|
India | Rs5.27 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Chongkundang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 001630 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chongkundang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chongkundang (2000–2024)
The table below shows the annual total liabilities of Chongkundang from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩646.03 Billion ≈ $437.80 Million |
+2.14% |
| 2023-12-31 | ₩632.52 Billion ≈ $428.65 Million |
+9.46% |
| 2022-12-31 | ₩577.83 Billion ≈ $391.59 Million |
+9.51% |
| 2021-12-31 | ₩527.67 Billion ≈ $357.59 Million |
+26.19% |
| 2020-12-31 | ₩418.15 Billion ≈ $283.37 Million |
+24.94% |
| 2019-12-31 | ₩334.67 Billion ≈ $226.80 Million |
+66.79% |
| 2018-12-31 | ₩200.66 Billion ≈ $135.98 Million |
+12.31% |
| 2017-12-31 | ₩178.67 Billion ≈ $121.08 Million |
+13.34% |
| 2016-12-31 | ₩157.64 Billion ≈ $106.83 Million |
+31.63% |
| 2015-12-31 | ₩119.76 Billion ≈ $81.16 Million |
+4.88% |
| 2014-12-31 | ₩114.19 Billion ≈ $77.39 Million |
+23.82% |
| 2013-12-31 | ₩92.22 Billion ≈ $62.50 Million |
-71.48% |
| 2012-12-31 | ₩323.37 Billion ≈ $219.14 Million |
+2.27% |
| 2011-12-31 | ₩316.20 Billion ≈ $214.29 Million |
+11.83% |
| 2010-12-31 | ₩282.76 Billion ≈ $191.62 Million |
+21.66% |
| 2009-12-31 | ₩232.41 Billion ≈ $157.50 Million |
-6.04% |
| 2008-12-31 | ₩247.36 Billion ≈ $167.63 Million |
+6.88% |
| 2007-12-31 | ₩231.43 Billion ≈ $156.84 Million |
-1.42% |
| 2006-12-31 | ₩234.76 Billion ≈ $159.09 Million |
+8.10% |
| 2005-12-31 | ₩217.18 Billion ≈ $147.18 Million |
+4.71% |
| 2004-12-31 | ₩207.40 Billion ≈ $140.55 Million |
-26.46% |
| 2003-12-31 | ₩282.04 Billion ≈ $191.14 Million |
-7.50% |
| 2002-12-31 | ₩304.89 Billion ≈ $206.62 Million |
-1.72% |
| 2001-12-31 | ₩310.22 Billion ≈ $210.23 Million |
-13.22% |
| 2000-12-31 | ₩357.49 Billion ≈ $242.26 Million |
-- |
About Chongkundang
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. Chong Kun Dang Holdings Corp. was founded in 1941 and is based in Seoul, South Korea.